Infectious Disease
COVID-19
Sargramostim Use in COVID-19 to Recover Patient Health (SCOPE)
Study of Sargramostim in Patients With COVID-19 (iLeukPulm)
Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC)
Using GM-CSF as a Host Directed Therapeutic Against COVID-19
A Phase II/III Study of Sargramostim in Patients With Coronavirus Disease-2019 (COVID-19) (Japan)
Cancer
Hematologic Malignancies
GM-CSF With Post-Transplant Cyclophosphamide
Solid Tumors
Sargramostim With Ipilimumab Containing Therapy in Patients With Solid Tumors (SALIENT)
Melanoma
Biliary Cancer
Pembrolizumab and GM-CSF in Biliary Cancer
Lung Cancer
Neurology
Parkinson’s disease
Biomarker Assessments of Leukine During Treatment of Parkinson’s Disease
Alzheimer’s Disease
Study of the Safety & Efficacy of Leukine® in the Treatment of Alzheimer’s Disease
Vascular
Peripheral Arterial Disease
Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease (GPAD-3)
Note: Not all clinical trials including sargramostim are listed.